These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34315630)

  • 1. 2-Aminoethyl diphenylborinate inhibits bleomycin-induced skin and pulmonary fibrosis via interrupting intracellular Ca
    Hsu WL; Hsieh YC; Yu HS; Yoshioka T; Wu CY
    J Dermatol Sci; 2021 Aug; 103(2):101-108. PubMed ID: 34315630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential new approach for treating systemic sclerosis: Dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry.
    Wu CY; Hsu WL; Tsai MH; Chai CY; Yen CJ; Chen CH; Lu JH; Yu HS; Yoshioka T
    PLoS One; 2019; 14(3):e0213400. PubMed ID: 30870448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cysteine proteinase inhibitor ALLN alleviates bleomycin-induced skin and lung fibrosis.
    Kasamatsu H; Chino T; Hasegawa T; Utsunomiya N; Utsunomiya A; Yamada M; Oyama N; Hasegawa M
    Arthritis Res Ther; 2023 Aug; 25(1):156. PubMed ID: 37626391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The compound LG283 inhibits bleomycin-induced skin fibrosis via antagonizing TGF-β signaling.
    Utsunomiya A; Chino T; Kasamatsu H; Hasegawa T; Utsunomiya N; Luong VH; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Oyama N; Hasegawa M
    Arthritis Res Ther; 2022 Apr; 24(1):94. PubMed ID: 35488265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
    Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
    Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
    Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
    Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
    Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis.
    Tomcik M; Zerr P; Pitkowski J; Palumbo-Zerr K; Avouac J; Distler O; Becvar R; Senolt L; Schett G; Distler JH
    Ann Rheum Dis; 2014 Jun; 73(6):1215-22. PubMed ID: 23661493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.
    Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W
    Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPB162-AE, an inhibitor of store-operated Ca
    Bittremieux M; Gerasimenko JV; Schuermans M; Luyten T; Stapleton E; Alzayady KJ; De Smedt H; Yule DI; Mikoshiba K; Vangheluwe P; Gerasimenko OV; Parys JB; Bultynck G
    Cell Calcium; 2017 Mar; 62():60-70. PubMed ID: 28196740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
    Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
    Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein-7 inhibits endothelial-to-mesenchymal transition in primary human umbilical vein endothelial cells and mouse model of systemic sclerosis via Akt/mTOR/p70S6K pathway.
    Shen C; Jiang Y; Li Q; Liu C; Hu F; Li M
    J Dermatol Sci; 2021 Aug; 103(2):82-92. PubMed ID: 34266726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between the JAK2 and TGF-β1 signaling pathways in scleroderma-related interstitial lung disease targeted by baricitinib.
    Wang D; Wei Y; Xu L; Zhang J
    Adv Rheumatol; 2023 May; 63(1):22. PubMed ID: 37194022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
    Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
    J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis.
    Bale S; Verma P; Yalavarthi B; Scarneo SA; Hughes P; Amin MA; Tsou PS; Khanna D; Haystead TA; Bhattacharyya S; Varga J
    JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37306632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.